drugset / Trial / NCT04489446

Sildenafil in COVID-19

NCT04489446

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomised trial aims to assess the role of sildenafil in improving oxygenation amongst hospitalised patients with COVID19.

Timeline

Start
2020-08-19
Primary completion
2021-04-30
Completion
2021-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 25 mg Oral

Indications